your tests could soon be transformed after researchers developed a “groundbreaking” low-cost device that can capture 3D images of the eye.
The device can capture images of the retina, back of the eye, and cornea and can be added to a slit lamp often used by optometrists to monitor eye health.
It is hoped that the new development will be able to identify conditions such as glaucoma and eye cancer.
Existing 3D imaging machines can cost up to £100,000, often making them too expensive for widespread use by the public.
A modified version of the technology could make it possible for people to take “selfies” of their retinas, meaning the machine can be used in uncontrolled environments such as pharmacies.
The device was developed by Dr Mario Giardini, Dr Ian Coghill and Kirsty Jordan of the Department of Biomedical Engineering at the University of Strathclyde.
Dr Giardini said: “Patients can be photographed easily and inexpensively, without the need for a specialist to be present. Our device reliably takes 3D images and is comfortable and fast in less than a second.
“The technology has the potential to revolutionize community screening and follow-up for conditions such as glaucoma, as any optometrist anywhere in the world could afford. This work makes eye diagnostics more accessible, reducing inequalities.”
Dr Iain Livingstone, Consultant Ophthalmologist at NHS Forth Valley, who has worked with Dr Giardini on previous ophthalmic projects, said: “So much of what we do as ophthalmologists depends on seeing things in 3D.
“It is a critical addition to the way we interpret information, leveraging digital to get so much more out of a slit lamp exam, with the potential well beyond the hospital towards community optometry, bringing nuanced measurement tools closer to home.” for patients.”
In partnership with IDCP Scotland, which produces digital technology, the device will now go into production with a grant from Scottish Enterprise.
Jamie Thomson, Managing Director of IDCP Scotland, said: “As an alumnus of the University of Strathclyde, I am proud to work closely with the team to help develop this technology, which has the potential to improve the quality of patient care and within IDCP Scotland’s key objective of revolutionizing patient care within ophthalmology.”